Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Legg

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|November 25, 2010
Development and implementation of treadmill exercise testing protocols in COPDChristopher B Cooper, Marlon Abrazado, Daniel Legg, et al.
Chest|April 6, 2013
Treadmill endurance during 2-year treatment with tiotropium in patients with COPD: a randomized trialChristopher B Cooper, Bartolome R Celli, José R Jardim, et al.
HIV Clinical Trials|April 20, 2010
Pharmacokinetic characterization of three doses of tipranavir boosted with ritonavir on highly active antiretroviral therapy in treatment-experienced HIV-1 patientsFrank D Goebel, Thomas R MacGregor, John P Sabo, et al.
Antimicrobial Agents and Chemotherapy|November 24, 2005
Interaction of ritonavir-boosted tipranavir with loperamide does not result in loperamide-associated neurologic side effects in healthy volunteersGeoffrey Mukwaya, Thomas MacGregor, David Hoelscher, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
International Journal of Chronic Obstructive Pulmonary Disease|November 25, 2010
Development and implementation of treadmill exercise testing protocols in COPDChristopher B Cooper, Marlon Abrazado, Daniel Legg, et al.
Chest|April 6, 2013
Treadmill endurance during 2-year treatment with tiotropium in patients with COPD: a randomized trialChristopher B Cooper, Bartolome R Celli, José R Jardim, et al.
HIV Clinical Trials|April 20, 2010
Pharmacokinetic characterization of three doses of tipranavir boosted with ritonavir on highly active antiretroviral therapy in treatment-experienced HIV-1 patientsFrank D Goebel, Thomas R MacGregor, John P Sabo, et al.
Antimicrobial Agents and Chemotherapy|November 24, 2005
Interaction of ritonavir-boosted tipranavir with loperamide does not result in loperamide-associated neurologic side effects in healthy volunteersGeoffrey Mukwaya, Thomas MacGregor, David Hoelscher, et al.
Pageof 1